The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2015

Filed:

Mar. 28, 2014
Applicant:

Los Angeles Biomedical Research Institute AT Harbor-ucla Medical Center, Torrance, CA (US);

Inventors:

Michael R. Yeaman, Redondo Beach, CA (US);

Arnold S. Bayer, Rancho Palos Verdes, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/60 (2006.01); A61K 38/14 (2006.01); A61K 31/603 (2006.01);
U.S. Cl.
CPC ...
A61K 31/603 (2013.01); A61K 31/60 (2013.01); A61K 38/14 (2013.01);
Abstract

The invention provides a method for preventing or treating a disease caused by an extracellular microorganism, said method comprising systemically administering to a subject in need thereof a prophylactically or therapeutically effective amount of a salicylic acid (SAL) or a SAL analog. The extracellular microorganism can be of the bacterial genus, for example,. The extracellular microorganism can be a strain that is resistant to at least one antibiotic. The strain can be selected from the group consisting of methycillin-resistant(MRSA), vancomycin-intermediate(VISA) and vancomycin-resistant(VRSA). The invention also provides a method for preventing or treating an infectious disease caused by of methycillin-resistant(MRSA), vancomycin-intermediate(VISA) or vancomycin-resistant(VRSA), comprising systemically co-administering in a synergistic combination to a subject in need thereof prophylactically or therapeutically effective amounts, individually or collectively, of a salicylic acid (SAL) or a SAL analog and at least one additional antimicrobial agent, for example, vancomycin and/or linezolid.


Find Patent Forward Citations

Loading…